|
Delayed
Bombay S.E.
05:39:13 03/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,945.00 INR | -0.05% |
|
-3.94% | +19.29% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Stock exchange
Bombay S.E.
GLAXO 2,946.60 ₹
-1.61%
9.77M
₹
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GLAXO | 2,946.60INR | -1.61% | 9.77M ₹ | ||
NSE India S.E.
| GLAXO | 2,949.90INR | -1.54% | 175M ₹ |
Quotes 5-day view: GlaxoSmithKline Pharmaceuticals Limited
Delayed Quote Bombay S.E.
| 28/08/2026 | 31/08/2026 | 01/09/2026 | 02/09/2026 | 03/09/2026 | |
|---|---|---|---|---|---|
| Last | ₹3,106.10 | ₹3,053.10 | ₹2,994.70 | ₹2,946.60 | ₹2,945.00 |
| Volume | 2,423 | 3,431 | 2,956 | 3,317 | 246 |
| Change | +1.23% | -1.71% | -1.91% | -1.61% | -0.05% |
| Opening | ₹3,082.05 | ₹3,120.60 | ₹3,004.70 | ₹2,990.00 | ₹2,946.65 |
| High | ₹3,121.10 | ₹3,120.60 | ₹3,034.15 | ₹2,990.00 | ₹2,955.35 |
| Low | ₹3,066.00 | ₹3,040.10 | ₹2,967.05 | ₹2,908.75 | ₹2,942.90 |
Performance
| 1 day | -1.61% | ||
| 1 week | -2.67% | ||
| Current month | -3.49% | ||
| 1 month | +11.05% | ||
| 3 months | +34.65% | ||
| 6 months | +16.20% | ||
| Current year | +19.25% | ||
| 1 year | +7.18% | ||
| 3 years | +104.85% | ||
| 5 years | +92.61% | ||
| 10 years | +97.94% |
Volumes
marketsDaily volume
3,317
Estimated daily volume
3,317
Avg. Volume 20 sessions
32,061
Daily volume ratio
0.1
Avg. Volume 20 sessions INR
94,470,942.6
Avg. Volume 20 sessions USD
994,873.5
Record volume 1
3,666,032
Record volume 2
2,829,462
Record volume 3
2,189,176
Capital turnover ratio
0
Basic data
Market Cap (INR)
504,963,422,959
Market Cap (USD)
5,345,491,127
Net sales (INR)
38,216,700,000
Net sales (USD)
404,558,076
Number of employees
3,103
Sales / Employee (INR)
12,316,049
Sales / Employee (USD)
130,376
Indicators
Moving average 5 days
3,049.95
Moving average 20 days
2,812.01
Moving average 50 days
2,610.07
Moving average 100 days
2,476.95
Price spread / (MMA5)
+3.51%
Price spread / (MMA20)
-4.57%
Price spread / (MMA50)
-11.42%
Price spread / (MMA100)
-15.94%
STIM
RSI 9 days
70.12
RSI 14 days
70.77
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.61% | -2.67% | +7.18% | +104.85% | 5.35B | |
| +0.01% | -2.47% | +57.79% | +108.23% | 1,034B | |
| +1.48% | +1.93% | +54.56% | +71.49% | 654B | |
| +0.67% | -0.45% | +23.50% | +76.60% | 459B | |
| +0.49% | -5.19% | +33.28% | +34.59% | 343B | |
| +0.27% | +3.26% | +29.76% | +46.97% | 307B | |
| +0.12% | -2.11% | +0.60% | +11.93% | 251B | |
| +1.08% | +0.57% | +54.34% | +72.51% | 237B | |
| +2.64% | -1.08% | -15.85% | -53.64% | 202B | |
| -0.21% | +1.03% | +32.74% | +95.19% | 186B | |
| Average | +0.49% | -1.23% | +27.79% | +56.87% | 367.69B | |
| Weighted average by Cap. | +0.63% | -1.31% | +38.81% | +67.36% |
Historical Quotes: GlaxoSmithKline Pharmaceuticals Limited
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
4338635725dd712afd2e3.FENT8yjbmw9MMKEybsZJ60sjrEIx1qMjd8FewyLPuCQ.ZXM6hxmI0EIcXuYBPIQNjRNplDRdhPRWPawfinf9jFA5JGCjQrDLSWFXmQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 10:57:39 | 2,965.50 | 30 | 3,317 |
| 10:57:26 | 2,960.00 | 1 | 3,287 |
| 10:56:51 | 2,951.80 | 2 | 3,286 |
| 10:56:08 | 2,946.40 | 230 | 3,284 |
| 10:56:03 | 2,948.10 | 58 | 3,054 |
| 10:56:02 | 2,948.10 | 1 | 2,996 |
| 10:55:53 | 2,955.80 | 6 | 2,995 |
| 10:55:14 | 2,952.90 | 13 | 2,989 |
| 10:52:30 | 2,946.55 | 51 | 2,976 |
Price Extremes
| 1 week | 2,908.75 |  | 3,121.1 |
| 1 month | 2,508.5 | | 3,121.1 |
| Current year | 2,088 | | 3,121.1 |
| 1 year | 2,088 | | 3,121.1 |
| 3 years | 1,387.9 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
Monthly variations
Annual variations
| 2026 | +19.25% | ||
| 2025 | +9.72% | ||
| 2024 | +18.69% | ||
| 2023 | +43.86% | ||
| 2022 | -25.08% | ||
| 2021 | +8.46% | ||
| 2020 | +0.93% | ||
| 2019 | +6.40% | ||
| 2018 | +21.86% | ||
| 2017 | -9.14% | ||
| 2016 | -17.79% | ||
| 2015 | +3.89% | ||
| 2014 | +6.82% | ||
| 2013 | +38.18% | ||
| 2012 | +11.84% | ||
| 2011 | -17.34% | ||
| 2010 | +45.50% | ||
| 2009 | +40.37% | ||
| 2008 | +11.36% | ||
| 2007 | -11.55% | ||
| 2006 | +3.95% | ||
| 2005 | +45.61% | ||
| 2004 | +33.79% | ||
| 2003 | +88.17% | ||
| 2002 | +6.33% | ||
| 2001 | -36.76% | ||
| 2000 | -37.81% | ||
| 1999 | +18.82% | ||
| 1998 | +50.74% | ||
| 1997 | +63.20% | ||
| 1996 | +6.27% |
- Stock Market
- Stocks
- GLAXO Stock
- Quotes GlaxoSmithKline Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
